Aligos Therapeutics Stock Price History

ALGS Stock  USD 22.99  1.64  7.68%   
If you're considering investing in Aligos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aligos Therapeutics stands at 22.99, as last reported on the 28th of November, with the highest price reaching 23.70 and the lowest price hitting 21.51 during the day. Aligos Therapeutics is risky given 3 months investment horizon. Aligos Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.58% are justified by taking the suggested risk. Use Aligos Therapeutics Mean Deviation of 6.53, risk adjusted performance of 0.1058, and Downside Deviation of 9.14 to evaluate company specific risk that cannot be diversified away.
  
At this time, Aligos Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 33.9 M in 2024, whereas Common Stock is likely to drop 4,767 in 2024. . At this time, Aligos Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 4.71 in 2024, whereas Price Earnings Ratio is likely to drop (4.94) in 2024. Aligos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1332

Best PortfolioBest Equity
Good Returns
Average ReturnsALGS
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 11.85
  actual daily
96
96% of assets are less volatile

Expected Return

 1.58
  actual daily
31
69% of assets have higher returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average Aligos Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aligos Therapeutics by adding it to a well-diversified portfolio.
Price Book
1.5291
Enterprise Value Ebitda
0.5749
Price Sales
13.7545
Shares Float
419.9 K
Wall Street Target Price
103.3333

Aligos Therapeutics Stock Price History Chart

There are several ways to analyze Aligos Stock price data. The simplest method is using a basic Aligos candlestick price chart, which shows Aligos Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 27, 202422.99
Lowest PriceOctober 10, 20246.89

Aligos Therapeutics November 28, 2024 Stock Price Synopsis

Various analyses of Aligos Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aligos Stock. It can be used to describe the percentage change in the price of Aligos Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aligos Stock.
Aligos Therapeutics Price Daily Balance Of Power 0.75 
Aligos Therapeutics Price Action Indicator 1.20 
Aligos Therapeutics Price Rate Of Daily Change 1.08 

Aligos Therapeutics November 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Aligos Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Aligos Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Aligos Stock and then apply it to test your longer-term investment strategies against Aligos.

Aligos Stock Price History Data

The price series of Aligos Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 16.1 with a coefficient of variation of 38.67. The prices are distributed with arithmetic mean of 11.84. The median price for the last 90 days is 9.83. The company had 1:25 stock split on 19th of August 2024.
OpenHighLowCloseVolume
11/28/2024
 22.61  23.70  21.51  22.99 
11/27/2024 22.61  23.70  21.51  22.99  278,654 
11/26/2024 20.48  22.46  19.50  21.35  371,657 
11/25/2024 20.30  21.89  19.50  20.46  435,758 
11/22/2024 20.01  20.44  18.75  20.04  437,524 
11/21/2024 18.17  19.98  17.26  19.79  637,020 
11/20/2024 18.51  19.85  17.88  18.20  495,961 
11/19/2024 19.79  24.84  14.65  18.50  1,523,932 
11/18/2024 19.45  20.15  17.85  20.12  387,247 
11/15/2024 19.91  20.59  17.26  19.17  423,745 
11/14/2024 19.43  20.44  15.66  19.46  672,548 
11/13/2024 18.80  21.89  18.20  19.58  1,220,378 
11/12/2024 15.46  18.00  14.09  17.85  1,478,114 
11/11/2024 10.32  17.70  10.32  13.99  3,161,531 
11/08/2024 9.87  10.41  9.68  10.19  108,249 
11/07/2024 9.08  10.45  9.02  9.92  174,545 
11/06/2024 10.00  10.00  9.20  9.35  75,675 
11/05/2024 9.51  9.88  9.32  9.83  78,813 
11/04/2024 9.58  9.89  9.35  9.48  52,362 
11/01/2024 9.81  10.30  9.33  9.55  61,471 
10/31/2024 10.05  10.05  8.88  9.78  147,965 
10/30/2024 9.37  10.39  9.12  9.77  360,116 
10/29/2024 8.82  9.40  8.43  9.36  123,894 
10/28/2024 8.41  9.27  8.18  8.87  181,150 
10/25/2024 9.14  9.20  8.10  8.40  200,937 
10/24/2024 7.16  10.35  7.10  9.03  921,026 
10/23/2024 7.37  7.45  7.16  7.21  21,261 
10/22/2024 7.36  7.55  7.10  7.34  44,650 
10/21/2024 7.38  7.38  7.09  7.29  10,058 
10/18/2024 7.28  7.43  7.19  7.25  9,720 
10/17/2024 7.19  7.39  7.16  7.21  17,386 
10/16/2024 7.32  7.43  7.15  7.38  28,771 
10/15/2024 7.45  7.45  7.04  7.27  15,758 
10/14/2024 7.60  7.60  6.98  7.23  80,942 
10/11/2024 6.85  7.70  6.85  7.62  62,684 
10/10/2024 7.61  7.75  6.84  6.89  83,555 
10/09/2024 7.22  7.85  7.21  7.76  31,585 
10/08/2024 7.57  7.72  6.76  7.32  69,605 
10/07/2024 8.06  8.17  7.50  7.50  49,357 
10/04/2024 8.23  8.48  7.93  8.16  37,959 
10/03/2024 8.44  8.67  8.01  8.19  36,196 
10/02/2024 8.49  8.82  8.37  8.59  28,949 
10/01/2024 8.57  9.19  8.36  8.62  31,939 
09/30/2024 7.96  9.77  7.96  8.66  77,736 
09/27/2024 8.02  8.17  7.83  8.04  51,456 
09/26/2024 8.22  8.37  7.82  8.02  29,175 
09/25/2024 8.15  8.48  8.02  8.22  33,217 
09/24/2024 8.50  8.50  7.35  8.15  129,005 
09/23/2024 9.09  9.35  7.80  8.10  114,035 
09/20/2024 10.60  10.95  9.14  9.14  238,862 
09/19/2024 12.81  13.11  9.90  10.18  875,365 
09/18/2024 14.34  15.25  14.00  14.16  62,076 
09/17/2024 14.41  14.90  13.68  14.39  30,616 
09/16/2024 14.67  15.07  14.06  14.22  31,671 
09/13/2024 13.87  15.30  13.82  14.80  41,535 
09/12/2024 14.38  16.24  13.30  14.03  95,027 
09/11/2024 14.17  14.75  13.35  13.80  101,944 
09/10/2024 18.52  18.52  12.86  13.79  259,945 
09/09/2024 13.15  19.50  12.46  19.43  488,764 
09/06/2024 11.70  12.57  11.35  12.51  26,972 
09/05/2024 11.50  11.98  11.17  11.94  29,488 

About Aligos Therapeutics Stock history

Aligos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aligos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aligos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aligos Therapeutics stock prices may prove useful in developing a viable investing in Aligos Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding24.9 M33.9 M
Net Loss-86.4 M-90.8 M

Aligos Therapeutics Quarterly Net Working Capital

76.01 Million

Aligos Therapeutics Stock Technical Analysis

Aligos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aligos Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aligos Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Aligos Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aligos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aligos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aligos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Aligos Stock Analysis

When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.